{
  "url": "https://openlegislation.uk/national-health-service-general-medical-services-amendment-wales-regulations-2003/regulation-3",
  "json_url": "https://openlegislation.uk/national-health-service-general-medical-services-amendment-wales-regulations-2003/regulation-3.json",
  "legislation": "wsi/2003/143",
  "legislation_title": "The National Health Service (General Medical Services) (Amendment) (Wales) Regulations 2003",
  "legislation_url": "https://openlegislation.uk/national-health-service-general-medical-services-amendment-wales-regulations-2003",
  "path": "regulation/3",
  "kind": "regulation",
  "number": "3",
  "heading": "Amendment of Schedule 11 to the principal Regulations",
  "text": "In Schedule 11 to the principal Regulations (drugs to be prescribed under pharmaceutical services only in certain circumstances)—\n(a) the entries relating to—\n(i) Acetylcysteine granules, and\n(ii) Carbocisteine\nshall be omitted, and\n(b) after “Apomorphine Hydrochloride (Uprima)” in columns 1 and 2 respectively, insert\n“, Tadalafil (Cialis)” .",
  "extent": null,
  "status": null,
  "version": "current",
  "annotations": [],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/wsi/2003/143/regulation/3",
    "retrieved_at": "2026-10-29T00:12:17.028799+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}